Investment HighlightsAs of March 31, 2023
Equity - Direct Investments | |||||||||||||||||||||
Winterfell
|
![]() |
![]() |
![]() |
||||||||||||||||||
Rochester3
|
![]() |
![]() |
![]() |
||||||||||||||||||
Arbors
|
![]() |
![]() |
![]() |
||||||||||||||||||
Aqua3
|
![]() |
![]() |
![]() |
||||||||||||||||||
Avamere
|
![]() |
![]() |
![]() |
Oak Cottage
|
![]() |
![]() |
![]() |
||||||||||||||
Equity - Direct Investments - SOLD | |||||||||||||||||||||
Franklin3
|
Cheektawaga
|
Anthenaeum
|
Harvard Square
|
||||||||||||||||||
Smyrna
|
Kansas City
|
Watermark Fountains
|
|
||||||||||||||||||
Equity - Unconsolidated Investments | |||||||||||||||||||||
Trilogy4
|
![]() |
![]() |
![]() |
||||||||||||||||||
Espresso
|
![]() |
![]() |
![]() |
||||||||||||||||||
Diversified US/UK
|
![]() |
![]() |
![]() |
||||||||||||||||||
Eclipse
|
![]() |
![]() |
![]() |
||||||||||||||||||
Equity - Unconsolidated Investments – REALIZED & SOLD | |||||||||||||||||||||
Envoy
|
Trilogy (partial ownership sale)
|
||||||||||||||||||||
Debt & Securities - REPAID & SOLD | |||||||||||||||||||||
Cedar Creek
|
Sava
|
Boyer
|
Freddie Mac (sale)
|
||||||||||||||||||
Espresso Mezzanine Loan
| |||||||||||||||||||||
1) For direct investments, amount represents operating real estate, before accumulated depreciation as presented in our consolidated financial statements as of March 31, 2023. For unconsolidated investments, amount represents the carrying value of our investments in unconsolidated ventures as presented in our consolidated financial statements as of March 31, 2023. 2) Classification based on predominant type of services provided at each property, but may include other services. 3) Owned jointly by NorthStar Healthcare and Freshwater for 97% and 3% interests, respectively. 4) Includes institutional pharmacy, therapy businesses and lease purchase buy-out options, which are not subject to property count. 5) Represents cumulative distributions received to date. |